⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL339786 | 0.70 | — | — | |
| SCHEMBL3978662 | 0.62 | — | — | |
| SCHEMBL14940573 | 0.53 | ALDH1A1 (0.30) | — | |
| SCHEMBL2406 | 0.53 | ALDH1A1 (0.30) | — | |
| SCHEMBL41780 | 0.53 | — | — | |
| SCHEMBL430968 | 0.50 | — | — | |
| Iodide SCHEMBL20500202 | 0.50 | — | — | |
| Bromide SCHEMBL20500171 | 0.50 | — | — | |
| SCHEMBL29289367 | 0.50 | — | — | |
| SCHEMBL5473985 | 0.50 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 166 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11208430-B2 | Modified oligonucleotides and methods for their synthesis | NOOGEN LLC (RU) | 2021-12-28 | — | — | US | claimed |
| US-10870674-B2 | — | — | 2020-12-22 | — | — | US | claimed |
| US-10766918-B2 | — | — | 2020-09-08 | — | — | US | claimed |
| US-10494388-B2 | Compounds useful in the synthesis of halichondrin B analogs | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2019-12-03 | — | — | US | claimed |
| US-20180162885-A1 | COMPOUNDS USEFUL IN THE SYNTHESIS OF HALICHONDRIN B ANALOGS | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2018-06-14 | — | — | US | claimed |
| US-9856276-B2 | Compounds useful in the synthesis of halichondrin B analogs | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2018-01-02 | — | — | US | claimed |
| US-9751909-B2 | Synthesis and uses of nucleic acid compounds with conformationally restricted monomers | MARINA BIOTECH, INC. (US) | 2017-09-05 | — | — | US | claimed |
| US-20160376294-A1 | COMPOUNDS USEFUL IN THE SYNTHESIS OF HALICHONDRIN B ANALOGS | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2016-12-29 | — | — | US | claimed |
| US-9382262-B2 | Compounds useful in the synthesis of halichondrin B analogs | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2016-07-05 | — | — | US | claimed |
| US-20150175620-A1 | COMPOUNDS USEFUL IN THE SYNTHESIS OF HALICHONDRIN B ANALOGS | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2015-06-25 | — | — | US | claimed |
| US-20110184190-A1 | COMPOUNDS USEFUL IN THE SYNTHESIS OF HALICHONDRIN B ANALOGS | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2011-07-28 | — | — | US | claimed |
| US-20110172438-A1 | Enantioselective Cascade Michael-Michael Reactions and Related Catalysts | NATIONAL SCIENCE FOUNDATION | 2011-07-14 | — | — | US | claimed |
| WO-2010027510-A2 | ENANTIOSELECTIVE CASCADE MICHAEL-MICHAEL REACTIONS AND RELATED CATALYSTS | STC. UNM (US) | 2010-03-11 | — | — | WO | claimed |
| EP-2001896-A2 | MONOMER COMPOSITIONS FOR THE SYNTHESIS OF RNA, METHODS OF SYNTHESIS, AND METHODS OF DEPROTECTION | Agilent Technologies, Inc. (US) | 2008-12-17 | — | — | EP | claimed |
| US-7342003-B2 | Synthesis of 2-aralkyloxyadenosines, 2-alkoxyadenosines, and their analogs | KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC. (US) | 2008-03-11 | — | — | US | claimed |
| WO-2007112263-A2 | MONOMER COMPOSITIONS FOR THE SYNTHESIS OF RNA, METHODS OF SYNTHESIS, AND METHODS OF DEPROTECTION | AGILENT TECHNOLOGIES, INC. (US) | 2007-10-04 | — | — | WO | claimed |
| US-20070100136-A1 | Monomer compositions for the synthesis of RNA, methods of synthesis, and methods of deprotection | AGILENT TECHNOLOGIES, INC. | 2007-05-03 | — | — | US | claimed |
| US-20060135466-A1 | Synthesis of 2-aralkyloxyadenosines, 2-alkoxyadenosines, and their analogs | KING PHARMACEUTICALS RESEARCH & DEVELOPMENT, INC. | 2006-06-22 | — | — | US | claimed |
| WO-2005033121-A2 | SYNTHESIS OF 2-ARALKYLOXYADENOSINES, 2-ALKOXYADENOSINES, AND THEIR ANALOGS | KING PHARMACEUTICALS RESEARCH & DEVELOPMENT, INC. (US) | 2005-04-14 | — | — | WO | claimed |
| EP-0365973-B1 | Process for preparing 4-0-alkyl-rhodomycins | BEHRINGWERKE AG (DE) | 1993-12-15 | — | — | EP | claimed |